Dock Pollen Allergy: The Overlooked Summer Weed
Dock pollen allergy is an IgE-mediated reaction to wind-borne pollen from Rumex species, commonly called dock or sorrel. It affects a small but consistent subset of weed-allergic patients, primarily during summer months (May–August). Symptoms include sneezing, nasal congestion, itchy eyes, and asthma exacerbations. While less potent than ragweed or grass pollen, dock pollen contributes to the summer weed pollen load and can cause clinically significant hay fever in sensitized individuals. Management follows standard weed pollen protocols: antihistamines, nasal corticosteroids, and allergen immunotherapy for persistent cases.
Free · 5 min · Insurance accepted
What Is Dock Pollen Allergy?
Dock pollen allergy is a seasonal IgE-mediated allergic rhinitis caused by wind-borne pollen from plants in the Rumex genus — commonly known as dock, sorrel, or patience.
Dock is a widespread weed found across the United States, particularly in disturbed soils, roadsides, pastures, and agricultural fields. While not as potent as ragweed or grass pollen, dock pollen contributes to the summer weed pollen load and can cause clinically significant hay fever symptoms in sensitized individuals.
The Rumex genus includes over 200 species worldwide, with curly dock (Rumex crispus) and broad-leaved dock (Rumex obtusifolius) being the most common in North America. These plants are wind-pollinated, meaning they release large quantities of lightweight pollen into the air — a key trait that makes them relevant aeroallergens despite their inconspicuous flowers. Dock pollen season typically runs from late spring through late summer, overlapping with grass pollen and other summer weeds, which can make it difficult to attribute symptoms to dock without specific testing.
Symptoms of Dock Pollen Allergy
Recognizing symptoms early helps you get the right treatment faster.
Sneezing
mildRepetitive sneezing triggered by dock pollen inhalation is a hallmark of IgE-mediated allergic rhinitis; most pronounced during peak pollen release hours.
Nasal congestion
mildMucosal swelling from histamine release causes nasal blockage and pressure; often worse in morning and evening when pollen settles near ground level.
Runny nose (rhinorrhea)
mildWatery nasal discharge occurs as part of the histamine-driven inflammatory response to inhaled dock pollen.
Itchy, watery eyes
mildAllergic conjunctivitis with itching, tearing, and redness is common in dock pollen-sensitized individuals exposed to airborne pollen.
Palatal and ear itching
mildDeep itching of the palate or ear canals is a characteristic feature of weed pollen allergy, distinct from infectious rhinitis.
Post-nasal drip and cough
mildMucus drainage from the nasal passages into the throat causes throat clearing, cough, and a sensation of a lump in the throat.
Asthma exacerbation
moderateIn patients with allergic asthma, dock pollen inhalation can trigger bronchoconstriction, wheezing, chest tightness, and cough.
When to see a doctor
Dock pollen allergy produces classic IgE-mediated hay fever symptoms that are indistinguishable from other weed pollen allergies. The hallmark presentation is seasonal allergic rhinitis (hay fever) occurring during the summer months, with sneezing, nasal congestion, runny nose, and itchy, watery eyes being the most common complaints. Some patients also experience palatal itching, ear itching, and post-nasal drip. Because dock pollen season overlaps with grass pollen and other summer weeds, patients may experience a prolonged symptom period from May through August or even September. The symptoms are typically most pronounced on warm, dry, windy days when pollen counts are highest, and improve on rainy days when pollen is washed from the air. In patients with allergic asthma, dock pollen inhalation can trigger bronchoconstriction, coughing, wheezing, and chest tightness. If you experience difficulty breathing, chest tightness, or throat swelling, seek emergency medical care immediately.
Dock Pollen and Asthma Risk
Dock pollen, like other weed pollens, can act as a trigger for asthma exacerbations in sensitized individuals. The relationship between weed pollen allergy and asthma is well documented: patients with allergic rhinitis sensitized to weed pollens have a 2–3 times higher risk of developing asthma compared to non-atopic individuals. The summer weed pollen season, which includes dock, overlaps with high ozone and particulate matter levels, creating a synergistic effect that can worsen asthma control. For patients with known asthma who experience worsening symptoms during the summer months, dock pollen should be considered as a potential trigger — particularly if symptoms correlate with outdoor activity on warm, dry, breezy days. Proper management includes optimizing controller medications before the pollen season begins, monitoring local pollen counts, and discussing allergen immunotherapy with an allergist to address the underlying allergic sensitivity.
Potential Complications of Dock Pollen Allergy
Untreated seasonal allergic rhinitis from dock pollen can progress to several clinically significant complications over time. Chronic nasal inflammation impairs mucociliary clearance, creating conditions that favor secondary bacterial sinusitis — characterized by facial pain, thick discolored nasal discharge, and reduced sense of smell. The persistent inflammation can also contribute to the development or worsening of asthma, a phenomenon described as the atopic march. Sleep disturbance is a common but underappreciated complication of untreated allergic rhinitis. Nasal congestion forces mouth breathing during sleep, leading to snoring, sleep fragmentation, and daytime fatigue. In children, this can impair school performance and quality of life. Chronic allergic inflammation can also contribute to the development of nasal polyps in susceptible individuals. Because dock pollen season overlaps with grass and other weed pollens, patients may experience a prolonged symptom period that can last 3–4 months without relief, leading to significant quality-of-life impairment if not properly managed.
Chronic sinusitis
Persistent nasal inflammation from untreated pollinosis can impair sinus drainage, leading to recurrent or chronic bacterial sinusitis requiring antibiotic or surgical intervention.
Asthma development or worsening
Long-term untreated allergic rhinitis from weed pollen sensitization is associated with a 2–3-fold increased risk of developing asthma over time.
Sleep disturbance and daytime fatigue
Nasal congestion forces mouth breathing during sleep, causing snoring, sleep fragmentation, and significant daytime fatigue and cognitive impairment.
Nasal polyps
Chronic allergic inflammation can contribute to the formation of nasal polyps in susceptible individuals, further obstructing nasal airflow.
What Causes Dock Pollen Reactions?
Dock pollen reactions are caused by IgE antibodies directed against specific proteins in Rumex pollen. While the molecular characterization of dock pollen allergens is less complete than for major pollens like ragweed or timothy grass, several protein families have been identified in Rumex species, including profilins and Ole e 1-like proteins that may contribute to cross-reactivity with other weed and grass pollens.
Curly dock
Rumex crispus
Broad-leaved dock
Rumex obtusifolius
Common sorrel
Rumex acetosa
Sheep sorrel
Rumex acetosella
Patience dock
Rumex patientia
How it works
Dock pollen allergy follows the classic Type I (IgE-mediated) hypersensitivity pathway. Inhaled Rumex pollen proteins bind to specific IgE antibodies on the surface of mast cells in the nasal mucosa and conjunctiva. Cross-linking of these IgE molecules triggers mast cell degranulation, releasing histamine, prostaglandins, and leukotrienes that cause vasodilation, increased mucus production, and nerve stimulation — producing sneezing, congestion, rhinorrhea, and ocular itching. The response is immediate (within minutes of exposure) and typically resolves within hours after pollen exposure ends.
The primary sensitization pathway begins when airborne dock pollen grains land on the nasal mucosa or conjunctiva of a genetically susceptible individual. Antigen-presenting cells process the pollen proteins and present them to T-helper cells, which stimulate B cells to produce allergen-specific IgE. This IgE binds to mast cells and basophils, priming them for future exposure. Upon re-exposure, cross-linking of surface IgE triggers degranulation and release of histamine, leukotrienes, and other inflammatory mediators that produce the classic symptoms of allergic rhinitis.
Dock pollen is primarily wind-dispersed, with peak release occurring during warm, dry, breezy conditions typical of summer afternoons. The pollen grains are relatively large (20–30 micrometers) compared to some other wind-pollinated plants, which may limit deep lung penetration but does not prevent nasal and ocular symptoms.
Risk factors to watch for
Residence in agricultural or disturbed areas
Dock thrives in pastures, roadsides, and fallow fields; patients living near these environments have higher ambient exposure to Rumex pollen.
Co-sensitization to grass or weed pollens
Patients already sensitized to grass pollen or other summer weeds (plantain, nettle) are at higher risk for developing dock pollen sensitization due to overlapping exposure seasons.
Family history of atopy
A personal or family history of allergic rhinitis, asthma, or eczema significantly increases the probability of developing IgE responses to any environmental allergen, including dock pollen.
Profilin sensitization
Profilins are pan-allergens found across plant pollens; patients with profilin sensitization may show positive IgE responses to dock pollen without primary Rumex sensitization.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How to Diagnose Dock Pollen Allergy
Diagnosing dock pollen allergy follows standard allergy testing protocols for weed pollen sensitization. The first step is a thorough clinical history: seasonal symptoms that occur during the summer months (May–August), correlate with outdoor activity on warm, dry days, and improve with antihistamines or nasal corticosteroids are suggestive of weed pollen allergy. Skin prick testing with commercial weed pollen extracts typically includes dock (Rumex) as part of a standard weed panel, along with ragweed, mugwort, English plantain, and nettle. A positive skin test result (wheal ≥3 mm larger than negative control) indicates IgE sensitization to dock pollen. Specific IgE blood testing (ImmunoCAP) is also available for Rumex species and can be used when skin testing is not feasible or when antihistamines cannot be discontinued. At-home allergy testing services such as Curex offer panels covering 40+ environmental allergens, including weed pollens, with results typically within 5 days and insurance coverage often available. This allows patients to identify their sensitization profile before consulting an allergist for confirmatory testing and treatment planning.
Skin prick test (SPT) with weed pollen panel
A standard weed pollen SPT panel includes dock (Rumex), ragweed, mugwort, English plantain, and nettle extracts. A wheal ≥3 mm larger than the negative control indicates sensitization.
Specific IgE blood test (ImmunoCAP)
Serology testing for IgE antibodies to Rumex species is available through major reference laboratories. Results are quantitative and not affected by antihistamines.
Component-resolved diagnostics
Molecular testing for pan-allergens like profilin and Ole e 1-like proteins can help distinguish primary dock sensitization from cross-reactivity with other weed or grass pollens.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
For patients whose dock pollen allergy is not adequately controlled by pharmacotherapy — or who want a disease-modifying treatment rather than daily symptom management — allergen immunotherapy is the only option that addresses the underlying immune response rather than just suppressing symptoms. The immunotherapy approach for dock pollen typically involves a multi-weed extract that includes dock along with other common summer weed allergens such as English plantain, mugwort, and nettle. This combination approach is practical because patients sensitized to dock are frequently co-sensitized to other summer weeds, and a single multi-allergen formulation addresses the full sensitization profile. Sublingual immunotherapy drops, available through providers like Curex starting at $39/month, allow patients to undergo desensitization at home without weekly clinic visits, and plans are typically covered by most insurance. The drops are taken daily under the tongue and absorbed through the oral mucosa, building immune tolerance over 3–5 years. Clinical trials in weed pollen-sensitized populations demonstrate 60–80% reduction in seasonal symptoms, with benefits often noticeable within the first treatment season.
Confirm dock pollen sensitization
Skin prick testing or specific IgE blood testing confirms IgE-mediated sensitivity to Rumex species before initiating immunotherapy.
Assess full weed pollen profile
Testing for co-sensitization to other summer weeds (plantain, mugwort, nettle) ensures the immunotherapy formulation addresses all relevant allergens.
Custom immunotherapy formulation
Allergen drops or shots are formulated based on the confirmed sensitization profile, typically including dock plus co-sensitized summer weeds.
3–5 year desensitization course
Gradually increasing allergen doses build immune tolerance; most patients experience significant improvement within 6–12 months.
“Clinical trials in weed pollen-sensitized populations show 60–80% reduction in seasonal rhinoconjunctivitis symptoms with allergen immunotherapy”
Treat your Dock Pollen allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With Dock Pollen Sensitivity
Managing dock pollen sensitivity is straightforward with the right combination of environmental awareness and medical management. The key is recognizing that dock pollen is a summer-season allergen that overlaps with grass and other weed pollens — so a comprehensive approach that addresses the full summer pollen profile is more effective than targeting dock alone. Creating a symptom diary during the summer months helps identify which days are worst and correlates with local pollen count data. This information is invaluable for an allergist designing an immunotherapy protocol or adjusting medication timing. Patients who know they are dock pollen-sensitive can plan outdoor activities for early morning or after rain, when pollen counts are lowest. For patients with allergic asthma, having a written asthma action plan that accounts for the summer weed pollen season is essential. This includes knowing when to increase controller medications, when to use rescue inhalers, and when to seek medical care for worsening symptoms.
Know your summer pollen profile
Dock pollen is one of several summer weed allergens. A complete allergy test reveals whether dock, plantain, mugwort, or nettle — or a combination — is driving your symptoms.
Plan outdoor activities strategically
Pollen counts are highest on warm, dry, breezy afternoons. Schedule outdoor activities for early morning or after rain, when pollen is washed from the air.
Create a summer symptom diary
Track daily symptoms, medication use, and outdoor exposure during May–August. This data helps your allergist identify patterns and optimize treatment timing.
Seasonal Patterns
May - June
medium intensity
June - August
high intensity
September
low intensity
Prevention Tips
Monitor local pollen counts
Use the National Allergy Bureau or weather app pollen tracking to identify high-count days and proactively limit outdoor exposure during peak hours.
Keep windows closed in summer
Close windows and use air conditioning with HEPA filtration during May–August to reduce indoor dock pollen levels.
Shower after outdoor exposure
Showering and changing clothes after time outdoors removes pollen from hair, skin, and clothing that would continue causing indoor exposure.
Pre-season medication start
Beginning intranasal corticosteroids 1–2 weeks before the expected dock pollen season reduces the initial inflammatory response and controls symptoms more effectively.
Use saline nasal rinses
Saline nasal irrigation after outdoor exposure helps mechanically flush pollen from the nasal passages, reducing symptom severity.
Outlook for Dock Pollen Allergy
The prognosis for dock pollen allergy is generally favorable. Most patients achieve adequate symptom control with standard pharmacotherapy — antihistamines and intranasal corticosteroids — during the summer pollen season. The condition is typically mild to moderate in severity, and systemic anaphylaxis from dock pollen inhalation has not been reported. For patients pursuing allergen immunotherapy, the outlook is excellent. Clinical trials in weed pollen-sensitized populations demonstrate 60–80% long-term symptom reduction, with benefits often noticeable within the first treatment season. Immunotherapy is the only disease-modifying treatment that can reduce the need for daily medications and prevent the progression of allergic rhinitis to asthma. Children with dock pollen allergy may experience improvement or resolution of symptoms as they age, though this is less predictable than with some other childhood allergies. Adults who develop dock pollen allergy later in life typically require ongoing management.
Key takeaways
Dock pollen allergy is a mild-to-moderate seasonal condition that responds well to standard pharmacotherapy
Immunotherapy offers 60–80% symptom reduction and is the only disease-modifying treatment option
The condition is not associated with anaphylaxis from pollen inhalation
Children may outgrow dock pollen allergy, though this is less predictable than with some other allergies
Diet and Dock Pollen Cross-Reactivity
Dietary cross-reactivity is a consideration for dock pollen allergy, particularly for patients sensitized via profilin or Ole e 1-like proteins. The Rumex genus includes edible species such as common sorrel (Rumex acetosa) and sheep sorrel (Rumex acetosella), which are used in soups, salads, and herbal preparations. These plants contain oxalic acid (responsible for the sour taste) and may also contain pollen-related proteins that could theoretically trigger oral allergy symptoms in sensitized individuals. However, documented cases of oral allergy syndrome specifically linked to dock pollen sensitization are rare in the published literature. The profilin-mediated cross-reactivity that occurs with dock pollen is similar to that seen with other weed pollens — patients with profilin sensitization may experience oral tingling with raw celery, melons, or stone fruits, but this is driven by the pan-allergen profilin rather than dock-specific proteins. Cooking destroys profilin, so cooked versions of these foods are typically tolerated.
Foods to limit
Raw sorrel (Rumex acetosa) — theoretical risk
Sorrel is a Rumex species; patients sensitized to dock pollen may theoretically react to raw sorrel leaves, though documented cases are rare.
Raw celery (profilin-sensitized patients only)
Profilin cross-reactivity may cause oral tingling in profilin-sensitized individuals; cooked celery is typically tolerated.
Raw melon (profilin-sensitized patients only)
Pan-allergen profilin in melons may trigger oral allergy syndrome in profilin-sensitized individuals.
Frequently Asked Questions
Dock and sorrel are common names for plants in the same genus, Rumex. Generally, 'dock' refers to larger, broader-leaved species like Rumex crispus (curly dock) and Rumex obtusifolius (broad-leaved dock), while 'sorrel' refers to smaller, more delicate species like Rumex acetosa (common sorrel) and Rumex acetosella (sheep sorrel). Both types produce wind-borne pollen that can cause allergic rhinitis in sensitized individuals. Sorrel is also cultivated as a culinary herb for its tangy, lemony flavor, while dock is typically considered a weed. From an allergy perspective, the pollen from all Rumex species is cross-reactive, so sensitization to one species implies reactivity to others.
Dock pollen allergy is less common than ragweed or grass pollen allergy, but it is a recognized and clinically significant aeroallergen in weed pollen panels. Prevalence estimates suggest that approximately 2–3% of the general population may show IgE sensitization to Rumex pollen on skin prick testing, with higher rates in agricultural regions where dock is abundant. Among patients presenting with summer hay fever symptoms, dock sensitization is found in a minority of cases — typically 5–15% depending on geographic region and the specific weed panel used. It is most relevant in the Midwest, Northeast, and Pacific Northwest regions of the United States.
No cases of anaphylaxis from dock pollen inhalation have been documented in the published literature. Like other weed pollen allergies, the primary presentation is rhinoconjunctivitis (sneezing, runny nose, itchy eyes) and occasionally mild asthma exacerbation. Pollen-mediated anaphylaxis is extraordinarily rare for any weed pollen. However, if a patient with dock pollen sensitization consumes raw sorrel leaves and experiences oral symptoms, theoretically mild systemic reactions are possible — though these are typically self-limited. Any patient who experiences throat swelling, hives, or difficulty breathing after any exposure should seek emergency care immediately.
Yes, dock (Rumex) pollen extract is included in standard weed pollen panels used for skin prick testing in most allergy clinics across the United States. Commercial extracts for Rumex species are available from major allergen extract manufacturers. A positive skin test result (wheal ≥3 mm larger than the negative control) indicates IgE sensitization to dock pollen. Specific IgE blood testing (ImmunoCAP) for Rumex species is also available through major reference laboratories. If you have summer hay fever symptoms, your allergist can include dock in your testing panel to determine whether it is contributing to your symptoms.
Oral allergy syndrome linked to dock pollen is possible but uncommon. The Rumex genus includes edible species like common sorrel (Rumex acetosa), and patients sensitized to dock pollen may theoretically experience oral tingling or throat itch when consuming raw sorrel leaves. More commonly, the profilin-mediated cross-reactivity that occurs with dock pollen can cause oral allergy symptoms with raw celery, melons, or stone fruits — but this is driven by the pan-allergen profilin rather than dock-specific proteins. Oral allergy symptoms from profilin are typically mild and self-limiting, resolving within 15–30 minutes without treatment. Cooking destroys profilin, so cooked versions of these foods are usually well-tolerated.
The highest-risk individuals are those living in agricultural or rural areas where dock is abundant — particularly the Midwest, Northeast, and Pacific Northwest regions of the United States. People who spend significant time outdoors during the summer months (farmers, landscapers, construction workers, outdoor athletes) have higher ambient exposure to dock pollen. Patients who are already sensitized to other weed pollens (ragweed, mugwort, English plantain) or grass pollens are at higher risk for developing dock pollen sensitization due to overlapping exposure seasons and shared protein families. A personal or family history of atopic disease (eczema, food allergy, other pollen allergies) significantly increases the probability of additional sensitizations.
The pharmacotherapy approach — antihistamines, intranasal corticosteroids, eye drops — is identical for dock pollen allergy and ragweed allergy. The primary difference is the timing: dock pollen season is May–August, while ragweed season is August–October (in most of the US). This means patients with dock allergy need to start medications earlier in the summer, while ragweed patients start later. For immunotherapy, the allergen extracts differ: dock immunotherapy uses Rumex extract, while ragweed immunotherapy uses Ambrosia extract. However, many patients are co-sensitized to multiple summer and fall weeds, so a multi-weed immunotherapy formulation is common.
Yes, new-onset respiratory allergies can develop at any age, including middle adulthood and beyond. The mechanism is the same regardless of age: repeated exposure to dock pollen in a genetically susceptible individual can eventually drive IgE sensitization and symptomatic rhinoconjunctivitis. Adults who move to agricultural regions where dock is abundant and experience their first summer hay fever symptoms after the move may be developing new dock pollen sensitization driven by regional exposure they did not have previously. This clinical presentation — 'I never had summer allergies before I moved to the Midwest' — should prompt evaluation with a weed pollen panel and is entirely consistent with adult-onset sensitization.
There is no cure for dock pollen allergy in the sense of permanently eliminating the immune response. However, allergen immunotherapy (allergy shots or sublingual drops) is the only disease-modifying treatment that can induce long-term immune tolerance, reducing or eliminating symptoms for years after the treatment course is completed. Clinical trials in weed pollen-sensitized populations demonstrate 60–80% symptom reduction with immunotherapy, and many patients experience sustained benefit for 5–10 years or longer after completing a 3–5 year treatment course. This is as close to a 'cure' as modern allergy medicine offers, though some patients may eventually require a booster course if symptoms return.
Dock (Rumex) belongs to the Polygonaceae family (the buckwheat or knotweed family), which also includes buckwheat (Fagopyrum esculentum), rhubarb (Rheum rhabarbarum), and Japanese knotweed (Reynoutria japonica). While these plants share family membership, the clinical relevance of cross-reactivity between dock pollen and these food plants is not well established. Buckwheat is a known food allergen in some populations, particularly in Asia, but this is a separate immune response from dock pollen sensitization. Rhubarb stalks are edible, but the leaves contain oxalic acid (also found in sorrel) and are toxic in large quantities — though this is a toxicological concern, not an allergic one.
Medical References
- [1]American Academy of Allergy, Asthma & Immunology. Weed Pollen Allergy. AAAAI, 2023.
- [2]American College of Allergy, Asthma & Immunology. Weed Pollen Allergy. ACAAI, 2023.
- [3]Asthma and Allergy Foundation of America. Pollen Allergy. AAFA, 2023.
- [4]Mayo Clinic. Seasonal allergies: Nip them in the bud. Mayo Clinic, 2023.
- [5]Cleveland Clinic. Allergic Rhinitis (Hay Fever). Cleveland Clinic, 2023.
- [6]National Institute of Allergy and Infectious Diseases. Pollen Allergy. NIAID, 2023.
- [7]D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007;62(9):976–990.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Dock Pollen allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
